Citation Impact
Citing Papers
Randomized Phase III Study of Surgery Alone or Surgery Plus Preoperative Cisplatin and Gemcitabine in Stages IB to IIIA Non–Small-Cell Lung Cancer
2011
Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer
2008 Standout
Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non–Small-Cell Lung Cancer
2010 Standout
Cutaneous leishmaniasis: current and future management
2003
Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): The TRIPOD statement
2015 Standout
Reporting methods in studies developing prognostic models in cancer: a review
2010
Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
2018 Standout
The Diagnostic and Therapeutic Utility of Thoracoscopy
1995
Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement
2015 Standout
Le traitement chirurgical du cancer bronchique non à petites cellules
2004
Leishmaniasis
2018 Standout
Towards better clinical prediction models: seven steps for development and an ABCD for validation
2014 Standout
Cutaneous leishmaniasis in the returning traveler
2005
Establishing the Diagnosis of Lung Cancer
2013 Standout
MALAT-1, a novel noncoding RNA, and thymosin β4 predict metastasis and survival in early-stage non-small cell lung cancer
2003 Standout
Chemistry and biology of monoterpene indole alkaloid biosynthesis
2006 Standout
Mechanisms of experimental resistance of Leishmania to miltefosine: Implications for clinical use
2006
Characterisation of Leishmania donovani promastigotes resistant to hexadecylphosphocholine (miltefosine)
2003
Quinoxaline, its derivatives and applications: A State of the Art review
2014 Standout
GRADE guidelines: 4. Rating the quality of evidence—study limitations (risk of bias)
2011 Standout
Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?
2007 Standout
Repeat FDG-PET After Neoadjuvant Therapy is a Predictor of Pathologic Response in Patients With Non-Small Cell Lung Cancer
2004
Randomized, Double-Blind Clinical Trial of Topical Imiquimod 5% with Parenteral Meglumine Antimoniate in the Treatment of Cutaneous Leishmaniasis in Peru
2005
Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
2009 Standout
Effectiveness of Antimalarial Drugs
2005
ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy)
2009 Standout
Preoperative versus Postoperative Chemotherapy in Patients with Resectable Non-small Cell Lung Cancer: Systematic Review and Indirect Comparison Meta-Analysis of Randomized Trials
2009
Treatment of Non-small Cell Lung Cancer-Stage IIIA
2007
Leishmaniavaccines: progress and problems
2006
Treatment of cutaneous leishmaniasis among travellers
2004
Prognostic factors in non-small cell lung cancer surgery
2005
Long-term survival after non–small cell lung cancer surgery: Development and validation of a prognostic model with a preoperative and postoperative mode
2006
BTS guidelines for the management of pleural infection in children
2005 Standout
Cutaneous leishmaniasis
2007 Standout
Cutaneous and mucocutaneous leishmaniasis
2009
Improved results of induction chemoradiation before surgical intervention for selected patients with stage IIIA-N2 non–small cell lung cancer
2007
Sensitivities of Leishmania species to hexadecylphosphocholine (miltefosine), ET-18-OCH3 (edelfosine) and amphotericin B
2002
Medical thoracoscopy in the diagnosis of unexplained pleural effusion
1998
Chemotherapy of Leishmaniasis: Past, Present and Future
2007
Preoperative chemotherapy for non-small cell lung cancer
2001
The role of chemotherapy in early stage of non-small cell lung cancer
2001
Novel hybrid selenosulfonamides as potent antileishmanial agents
2014
Erlotinib in Previously Treated Non–Small-Cell Lung Cancer
2005 Standout
Miltefosine for New World Cutaneous Leishmaniasis
2004
The Impact of Thoracoscopy on the Management of Pleural Disease
1995
Thoracoscopy: A review of 121 consecutive surgical procedures
1989
Chemotherapy in the Treatment and Control of Leishmaniasis
2006
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
The IASLC Lung Cancer Staging Project: Proposals for the Revisions of the T Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer
2015
Investigation of a unilateral pleural effusion in adults: British Thoracic Society pleural disease guideline 2010
2010 Standout
Taxanes in the Treatment of Non-Small Cell Lung Cancer
2006
Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2017 Standout
Cutaneous Leishmaniasis in Travellers: a Focus on Epidemiology and Treatment in 2015
2015
Pharmaceutical and medicinal significance of sulfur (SVI)-Containing motifs for drug discovery: A critical review
2018 Standout
Survival improvement in resectable non-small cell lung cancer with (neo)adjuvant chemotherapy: Results of a meta-analysis of the literature
2005
Mortality due to cancer treatment delay: systematic review and meta-analysis
2020 Standout
Mechanisms of drug combinations: interaction and network perspectives
2009 Standout
An initial experience with FDG-PET in the imaging of residual disease after induction therapy for lung cancer
2002
Miltefosine to treat leishmaniasis
2005
Oral Miltefosine for Leishmaniasis in Immunocompromised Patients: Compassionate Use in 39 Patients with HIV Infection
2004
Leishmaniasis: new approaches to disease control
2003
Leishmaniasis– current chemotherapy and recent advances in the search for novel drugs
2003
Management of malignant pleural effusions
2001 Standout
Diagnosis and Treatment of Tuberculous Pleural Effusion in 2006
2007 Standout
Early-Stage Non–Small-Cell Lung Cancer: Current Perspectives in Combined-Modality Therapy
2004
Survival After Community Diagnosis of Early-stage Non-small Cell Lung Cancer
2014
Reporting performance of prognostic models in cancer: a review
2010
Thoracoscopy for the Diagnosis of Pleural Disease
1991
PEGylation, successful approach to drug delivery
2005 Standout
Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD Statement
2015 Standout
El llamado derrame pleural maligno: una nueva revisión sobre aspectos directos extraídos mediante la pleuroscopia diagnóstica
1996
The Cure Rate after Placebo or No Therapy in American Cutaneous Leishmaniasis: A Systematic Review and Meta-Analysis
2016
From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors
2009 Standout
Thoracoscopy--state of the art
1998
Preoperative chemotherapy in patients with resectable non-small cell lung cancer: results of the MRC LU22/NVALT 2/EORTC 08012 multicentre randomised trial and update of systematic review
2007
Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship
2008 Standout
Control of Neglected Tropical Diseases
2007 Standout
Tuberculous pleural effusions: Ultrasonic diagnosis
1992
The autoclavable semirigid thoracoscope: the way forward in pleural disease?
2007
LeishMan Recommendations for Treatment of Cutaneous and Mucosal Leishmaniasis in Travelers, 2014
2013
Atroposelective Total Synthesis of Axially Chiral Biaryl Natural Products
2010 Standout
Preoperative Chemotherapy Plus Surgery Versus Surgery Plus Adjuvant Chemotherapy Versus Surgery Alone in Early-Stage Non–Small-Cell Lung Cancer
2010
Pleural effusion in breast cancer. Thoracoscopy for hormone receptor determination
1986
Talc pleurodesis
1993
From radiotherapy to Targeted therapy: 20 years in the management of non-small-cell lung cancer.
2006
Cutaneous leishmaniasis – Authors' reply
2008 Standout
Thoracoscopy: assessment of a physician service and comparison of a flexible bronchoscope used as a thoracoscope with a rigid thoracoscope.
1988
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
Topical treatment for cutaneous leishmaniasis.
2002
Thoracoscopy
1979
Interventions for American cutaneous and mucocutaneous leishmaniasis
2009
Lung Cancer and Pleural Effusion
1985
Therapeutic Glucocorticoid-Induced TNF Receptor-Mediated Amplification of CD4+ T Cell Responses Enhances Antiparasitic Immunity
2010 StandoutNobel
Current scenario of drug development for leishmaniasis.
2006
A Systematic Review and Meta-analysis of the Literature: Chemotherapy and Surgery versus Surgery Alone in Non-small Cell Lung Cancer
2006
Advances in leishmaniasis
2005 Standout
A systematic review and meta-analysis of the literature: chemotherapy and surgery versus surgery alone in non-small cell lung cancer.
2006
Artificial intelligence in cancer imaging: Clinical challenges and applications
2019 Standout
Thoracoscopy under regional anesthesia for the diagnosis and management of pleural disease
1987
Pleural metastatic tumours and effusions. Frequency and pathogenic mechanisms in a post-mortem series
1989
Reactive species in non-equilibrium atmospheric-pressure plasmas: Generation, transport, and biological effects
2016 Standout
Activities of Naphthylisoquinoline Alkaloids and Synthetic Analogs againstLeishmania major
2006
Thoracoscopy: present diagnostic and therapeutic indications
1993
Leishmania donovani Resistance to Miltefosine Involves a Defective Inward Translocation of the Drug
2003
Diagnosis and Management of Cerebral Venous Thrombosis
2011 Standout
Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group
2008 Standout
Targeting nitric oxide for cancer therapy
2007
Chloroquine or amodiaquine combined with sulfadoxine-pyrimethamine for treating uncomplicated malaria
2005
Cisplatin-Based Adjuvant Chemotherapy in Patients with Completely Resected Non–Small-Cell Lung Cancer
2004 Standout
Preoperative chemotherapy in patients with resectable non-small cell lung cancer: results of the MRC LU22/NVALT 2/EORTC 08012 multicentre randomised trial and update of systematic review
2008
Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship
2008 Standout
THE SENSITIVITY OF CLINICAL ISOLATES OF LEISHMANIA FROM PERU AND NEPAL TO MILTEFOSINE
2005
Combination of Suboptimal Doses of Inhibitors Targeting Different Domains of LtrMDR1 Efficiently Overcomes Resistance of Leishmania spp. to Miltefosine by Inhibiting Drug Efflux
2006
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): The TRIPOD Statement
2015 Standout
Diagnosis and Treatment of Leishmaniasis: Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH)
2016
CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials
2010 Standout
Drug Resistance in Leishmaniasis
2006 Standout
A Systematic Review and Meta-analysis of the Literature: Chemotherapy and Surgery versus Surgery Alone in Non-small Cell Lung Cancer
2006
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
2003 Standout
Miltefosine Susceptibility and Resistance in Leishmania: From the Laboratory to the Field
2016
Preoperative Chemotherapy Followed by Surgery Compared With Primary Surgery in Resectable Stage I (Except T1N0), II, and IIIa Non-Small-Cell Lung Cancer
2002
Points to Consider When Choosing A Biopsy Method in Cases of Pleurisy of Unknown Origin
1983
Works of J. Padilla being referenced
Treatment of American Cutaneous Leishmaniasis with Miltefosine, an Oral Agent
2001
Treatment of cutaneous leishmaniasis with a topical antileishmanial drug (WR279396): phase 2 pilot study.
2002
Preresectional chemotherapy in stage IIIA non-small-cell lung cancer: a 7-year assessment of a randomized controlled trial
1999
Resección de carcinoma broncogénico con invasión diafragmática
1999
Survival and risk model for stage IB non-small cell lung cancer
2002
Thoracoscopy in the diagnosis of pleural effusion.
1977
A risk model for non-small cell lung cancer using clinicopathological variables, angiogenesis and oncoprotein expression.
2005
Eficacia de amodiaquina y sulfadoxina/pirimetamina en el tratamiento de malaria no complicada por Plasmodium falciparum en Nariño, Colombia, 1999-2002.
2003